nation
institut
health
nih
largest
public
funder
biomed
research
worldwid
budget
grown
billion
billion
congress
public
rais
concern
diseasespecif
fund
alloc
nih
fail
adequ
reflect
burden
diseas
incorpor
public
input
respons
congress
request
institut
medicin
iom
assess
nih
fund
apportion
process
report
scientif
opportun
public
need
improv
prioriti
set
public
input
nation
institut
health
iom
recommend
improv
track
diseasespecif
fund
develop
new
priorityset
process
landmark
studi
compar
diseas
burden
nih
fund
level
publish
common
condit
studi
examin
varieti
measur
societ
burden
recogn
none
complet
captur
rel
impact
diseas
diseas
incid
preval
unrel
fund
mortal
year
life
lost
yll
weakli
correl
fund
disabilityadjust
life
year
dali
measur
estim
equival
number
healthi
year
lost
due
disabl
earli
death
strongli
predict
use
dali
best
singl
predictor
varianc
nih
fund
could
explain
prior
analysi
limit
evalu
univari
predictor
attempt
evalu
whether
fund
align
measur
diseas
burden
nih
reform
act
reemphas
nih
role
identifi
research
meet
public
health
challeng
mandat
submiss
biennial
report
congress
regard
diseasespecif
fund
amount
recent
comprehens
studi
us
diseas
burden
nih
fund
analysi
one
institut
perform
determin
whether
nih
develop
process
better
align
fund
burden
assess
correl
nih
fund
burden
diseas
compar
result
report
year
ago
also
consid
potenti
predictor
fund
assess
associ
nih
fund
estim
futur
global
diseas
burden
amount
nih
fund
diseas
categori
obtain
directli
nih
year
tabl
estim
annual
consolid
figur
suppli
individu
nih
institut
center
http
wwwnihgovnewsfundingresearchareashtm
prior
year
nih
institut
center
categor
spend
varieti
manner
satisfi
divers
report
requir
calcul
conditionspecif
total
fund
nonmutu
exclus
manner
thu
fund
particular
trial
biomark
could
attribut
multipl
condit
data
denot
diseas
burden
collect
multipl
sourc
tabl
first
world
north
american
diseasespecif
data
obtain
global
burden
diseas
gbd
project
world
health
organ
use
gbd
north
american
data
us
estim
gbd
systemat
collect
time
diseasespecif
epidemiolog
inform
model
miss
data
estim
varieti
measur
burden
use
gbd
estim
like
recent
publicli
avail
data
time
decis
made
fund
cycl
central
systemat
sourc
broad
nation
diseasespecif
burden
estim
identifi
evalu
five
diseas
burden
categori
gbd
incid
preval
mortal
yll
dali
yll
diseas
calcul
total
differ
life
expect
age
death
dali
estim
base
yll
standard
weight
scheme
disabl
appli
surviv
diseas
gbd
estim
us
base
analys
comprehens
death
certif
data
nation
incid
estim
systemat
review
publish
epidemiolog
studi
evalu
estim
diseas
burden
use
us
inpati
outpati
healthcar
databas
categor
diagnosi
includ
larg
sampl
weight
gener
nation
repres
estim
support
tabl
number
hospit
discharg
total
length
stay
mean
hospit
charg
diseasespecif
princip
diagnos
deriv
nation
inpati
sampl
ni
number
visit
emerg
depart
outpati
hospit
clinic
deriv
nation
hospit
ambulatori
care
survey
nhamc
nation
ambulatori
care
survey
namc
ni
nhamc
commun
hospit
defin
nonfeder
shortstay
hospit
public
interest
could
also
influenc
fund
level
lobbi
effort
addit
fund
support
privat
foundat
directli
stimul
interest
investig
could
influenc
fund
level
begin
assess
influenc
public
interest
determin
number
diseasespecif
newspap
articl
publish
top
us
newspap
highest
distribut
well
broadcast
televis
news
report
nation
network
use
diseasespecif
keyword
search
lexisnexi
news
vanderbilt
televis
news
archiv
estim
influenc
specif
interest
group
advocaci
total
us
diseasespecif
chariti
revenu
similarli
calcul
public
chariti
receiv
public
support
scientif
product
given
area
could
stimul
interest
research
nih
could
result
target
fund
surrog
measur
scientif
product
talli
number
diseasespecif
patent
submit
articl
publish
list
pubm
medic
journal
highest
impact
factor
score
use
key
word
search
relationship
nih
fund
level
us
diseas
burden
metric
design
priori
primari
analysi
predictor
outcom
variabl
logtransform
reduc
posit
skew
univari
linear
regress
first
perform
replic
prior
studi
design
approach
prefer
correl
allow
adjust
acknowledg
fund
level
depend
variabl
predict
expect
fund
level
calcul
correct
logtransform
appli
measur
diseas
burden
fit
model
predict
fund
account
inflat
actual
expect
fund
level
inflat
dollar
standard
forward
stepwis
multivari
linear
regress
analysi
includ
variabl
diseas
burden
includ
p
final
model
evalu
interact
fstatist
use
estim
differ
explanatori
power
signific
p
separ
forward
stepwis
multivari
model
constrain
diseas
burden
would
receiv
zero
fund
mimick
theoret
fund
process
determin
alloc
proport
diseas
burden
model
defin
depend
variabl
ratio
dollar
dali
includ
condit
separ
multivari
model
includ
measur
public
interest
scientif
product
addit
sensit
analys
evalu
associ
fund
level
worldwid
diseas
burden
project
us
worldwid
final
analysi
evalu
whether
new
nih
account
method
diseasespecif
fund
introduc
produc
differ
result
explanatori
power
model
estim
adjust
valu
adjust
valu
also
determin
analysi
fund
level
use
data
deriv
prior
public
stata
statist
packag
version
colleg
station
texa
use
analys
total
nih
budget
billion
billion
devot
includ
condit
diseas
fund
rang
million
peptic
ulcer
diseas
otiti
media
aid
median
deviat
tabl
metric
gbd
tabl
us
inpati
emerg
room
outpati
support
tabl
public
interest
scientif
opportun
support
tabl
vari
diseas
univari
analysi
nih
fund
strongli
associ
burden
diseas
measur
dali
p
tabl
yll
p
inpati
hospit
discharg
p
total
hospit
day
p
also
associ
fund
level
standard
multivari
analysi
dali
signific
predictor
nih
fund
level
retain
final
model
analysi
becam
univari
degre
correl
nih
fund
diseas
burden
measur
dali
alon
less
nih
fund
varianc
explain
compar
differ
actual
expect
fund
base
burden
diseas
dali
estim
compar
fund
level
tabl
figur
depress
receiv
least
fund
compar
expect
aid
consist
find
rel
expect
fund
aid
diabet
perinat
condit
three
diseas
largest
amount
fund
depress
injuri
copd
receiv
least
fund
tabl
largest
posit
gain
actual
nih
fund
rel
expect
aid
perinat
condit
diabet
contrast
injuri
depress
chronic
obstruct
pulmonari
diseas
ischem
heart
diseas
decreas
sharpli
figur
standard
multivari
regress
model
includ
measur
public
interest
scientif
product
total
chariti
revenu
given
diseas
p
also
predict
fund
addit
dali
p
model
includ
variabl
explain
variat
nih
fund
level
multivari
model
constrain
requir
diseas
result
burden
ill
receiv
nih
fund
equival
requir
intercept
zerozero
regress
line
express
dash
line
figur
expect
fund
amount
gener
similar
found
unconstrain
multivari
model
tabl
figur
determin
nih
fund
might
better
correl
world
futur
diseas
burden
perform
sensit
analys
global
measur
futur
project
deriv
gbd
project
support
tabl
restrict
global
measur
mortal
p
dali
p
predict
fund
univari
analys
adjust
valu
dali
retain
multivari
model
global
measur
futur
predict
correl
fund
diseas
burden
improv
data
util
new
nih
account
method
use
adjust
compar
prior
method
adjust
appli
data
first
year
new
method
avail
year
sinc
initi
assess
correl
nih
fund
diseas
burden
iom
report
recommend
new
nih
fund
priorityset
criteria
nih
fund
better
align
us
diseas
burden
furthermor
diseas
previous
fund
aid
breast
cancer
receiv
fund
greater
predict
burden
diseas
condit
previous
underfund
remain
underfund
ad
measur
diseas
burden
model
constrain
assur
diseas
burden
would
receiv
fund
minim
affect
overal
relationship
burden
fund
neither
global
futur
diseas
burden
close
relat
nih
fund
newli
implement
nih
diseasespecif
account
practic
improv
correl
although
iom
report
nih
fund
recommend
ongo
assess
align
nih
fund
diseas
burden
also
recogn
import
criteria
set
fund
prioriti
criteria
includ
research
qualiti
scientif
innov
opportun
portfolio
diversif
infrastructur
build
expert
propos
similar
framework
guid
fund
decis
addit
factor
consid
may
includ
transmiss
popul
risk
collater
benefit
diseas
control
public
interest
given
potenti
contributor
decisionmak
diseas
fund
perfect
align
dali
measur
diseas
burden
would
expect
unclear
particular
condit
remain
overfund
rel
diseas
burden
difficulti
attribut
basic
scienc
larg
portion
nih
individu
diseas
complic
implement
diseasebas
alloc
process
howev
discrep
particularli
dramat
spend
aid
research
diseas
greatest
fund
compar
expect
may
justifi
due
potenti
threat
associ
spread
past
success
treat
even
elimin
infecti
diseas
greater
burden
lower
incom
countri
howev
aid
fund
remain
greater
predict
even
worldwid
project
burden
consid
strong
polit
influenc
may
import
maintain
high
level
fund
us
also
congressionallymand
research
support
rare
ill
may
explain
greater
fund
diseas
littl
burden
condit
typic
associ
substanc
use
mental
health
diagnos
tend
underfund
eg
lung
cancer
chronic
obstruct
pulmonari
diseas
alcohol
depress
chariti
revenu
use
proxi
diseasespecif
interestgroup
advocaci
associ
fund
level
may
contribut
lobbi
effort
provid
collater
support
research
train
encourag
nih
submiss
specif
diseas
area
avail
proven
costeffect
intervent
eg
tobaccorel
prevent
strategi
may
also
influenc
fund
sinc
develop
new
intervent
may
unnecessari
effect
strategi
alreadi
identifi
interv
fund
sever
condit
notabl
increas
compar
expect
exampl
nation
institut
allergi
infecti
diseas
initi
concert
respons
bioterror
follow
terrorist
attack
sept
anthrax
incid
sever
acut
respiratori
syndrom
sar
outbreak
may
augment
support
pneumoniarel
research
convers
rel
fund
increas
perinat
condit
appear
primarili
due
reduct
associ
dali
last
decad
sinc
fund
increas
period
parallel
overal
growth
nih
budget
final
increas
rel
fund
diabet
research
may
precipit
congression
action
requir
develop
comprehens
diabet
research
plan
alloc
million
new
fund
program
type
diabet
research
lack
improv
align
fund
diseas
burden
may
indic
neglect
iom
recommend
nih
sever
possibl
explan
first
basic
scienc
research
consist
account
nih
spend
difficult
credit
specif
diseas
much
research
contribut
uncertainti
analysi
reduc
correl
fund
level
diseas
burden
second
nih
fund
commit
time
iom
public
could
redistribut
associ
project
complet
sometim
five
year
later
result
realloc
would
delay
sever
year
third
distribut
fund
among
nih
institut
determin
congress
incorpor
input
nih
scientist
health
care
provid
special
interest
group
thu
fiscal
polit
constraint
like
addit
temper
nih
abil
implement
iom
recommend
final
without
regard
overal
diseas
fund
align
substanti
financ
billion
nih
budget
invest
creation
three
new
center
nation
institut
biomed
imag
bioengin
center
complementari
altern
medicin
nation
center
minor
health
health
dispar
establish
crosscut
roadmap
initi
expand
emphasi
career
train
award
nih
recent
taken
step
integr
effect
iom
priorityset
criteria
divis
program
coordin
plan
strateg
initi
dpcpsi
establish
purpos
identifi
scientif
opportun
public
health
challeng
scientif
knowledg
gap
improv
portfolio
analysi
priorityset
consist
transpar
system
track
diseasebas
fund
launch
also
part
nih
billion
alloc
american
recoveri
reinvest
act
million
dedic
compar
effect
research
specif
evalu
effect
clinic
manag
comprehens
public
health
outcom
mortal
morbid
qualiti
life
studi
sever
limit
first
account
diseas
fund
nih
standard
reliabl
known
howev
altern
sourc
inform
publicli
avail
histor
new
account
method
yield
similarli
poor
correl
burden
second
evalu
sourc
feder
nonprofit
industri
fund
condit
wellfund
organ
nih
may
justifi
correspond
decreas
nih
fund
howev
sourc
feder
center
diseas
control
prevent
agenc
healthcar
research
qualiti
food
drug
depart
health
human
servic
dollar
dedic
life
scienc
research
similarli
total
life
scienc
research
dollar
spent
depart
defens
depart
veteran
affair
equival
less
total
amount
disburs
nih
thu
total
dollar
spent
complementari
project
feder
institut
fulli
explain
poor
correl
diseas
burden
nih
fund
although
biomed
pharmaceut
industri
research
fund
unit
state
time
amount
alloc
nih
fulli
dedic
support
clinic
trial
less
like
widespread
public
health
benefit
unfortun
fund
diseas
sector
avail
except
limit
therapeut
area
figur
exist
privat
foundat
third
global
estim
diseas
burden
gbd
uncertain
due
incomplet
bia
particularli
lowincom
countri
howev
estim
best
avail
particularli
accur
us
fourth
permit
comparison
prior
studi
make
studi
feasibl
mani
diseas
condit
fund
nih
omit
analysi
still
assess
respons
nih
prior
recommend
central
studi
power
would
expect
dramat
impact
find
fifth
prior
analysi
util
estim
world
market
economi
use
north
american
number
data
use
better
approxim
us
burden
strengthen
conclus
could
affect
assess
interv
chang
sinc
found
poorer
correl
fund
previou
estim
impact
conclus
final
none
measur
diseas
burden
individu
collect
fulli
captur
health
econom
cost
condit
better
metric
might
captur
true
societ
cost
diseas
comprehens
assess
total
healthcar
cost
valuat
death
dali
overal
fund
level
today
less
well
align
dali
compar
year
ago
suggest
iom
priorityset
recommend
implement
effect
account
measur
diseas
burden
substanti
improv
align
recipi
substanti
government
support
clear
articul
rational
nih
spend
may
expect
congress
public
lack
clear
align
measur
public
burden
could
encourag
special
interest
erod
scientif
independ
nih
rais
question
manag
use
consist
account
method
diseas
fund
comprehens
measur
burden
futur
risk
includ
impact
health
expenditur
time
dissemin
benchmark
align
diseas
burden
fund
could
help
make
nih
fund
prioriti
rational
transpar
